ended 30 September 2020 are as follows: change Q3/2020 Q3/2019 increase (decrease) Sales 277.7 172.6 60.9% Other income 2.5 4.1 -39.9% Cost of sales - 207.6 - 159.6 -30.1% Selling expenses - 7.9 - 4.5
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
income and cost of sales resultin g in the operating income until the gross profit being reported differently from the previous periods Operating Highlights in Q3/2019 Q3/18 Q2/192 Q3/19 Change +/(-) 9M/18
Financial Statements that are the 6-month financial statement ending 30 June 2016 which has been reviewed and audited by a certified public accountant, the 9-month financial statement ending 30 September 2016
value at change rate is 0.13 MYR per THB which is 15 days average exchange rate before the negotiation date between NDR and CRSB which is a period between August 18, 2017 and The above exchange rate is
Financial Reporting Standard No. 16 : Lease (TFRS 16), effective 1 January 2020, has impacted the Company and its subsidiaries’ financial statement in recognizing a right-of-use asset and a lease liability in
Page 1 from 5 Management Discussion and Analysis Performance for Quarter 3/2020 WICE Logistics Public Company Limited Performance Unit : million baht Statement of financial position Q3/2020 Q3/2019
in allowance of doubtful debt even though there was one-time administrative expenses as mentioned above. Statement of Financial Position Assets As at 30 September 2019, the Group had total assets of
market therefore, their sales has no affect to a significant change to the total sales in this quarter. As for the nine month-period ended September 30, 2019 the Company and its subsidiary still has a
Director approved financial statement on 11 May 2018. The Decree defined the definition of Digital Asset and has it objective to regulate the issuance and offering of cryptocurrencies and digital asset